Diligence memo · auto-generated · as of July 2, 2026

Arizona Nutritional Supplements, LLC

Arizona Nutritional Supplements, LLC looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Arizona Nutritional Supplements, LLC operates in Other Health Care, based in CHANDLER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Arizona Nutritional Supplements, LLC has raised $9.0M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $8.0M on 2023-10-27.

Most recent recorded round closed around 2023-10-27.

Valuation (modeled)modeled

Provath models Arizona Nutritional Supplements, LLC at approximately $49M (range $10M–$124M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.34× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era. Within the normal band (134% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 37 months.

Last raise 2.7 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 8.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 74% of Other Health Care peers (5377 compared).

Modeled value ranks above 67% of those peers.

Closest niche peers: CareHarmony, Inc., Dragonfly Endoscopy Inc., NuvoAir Holdings, Inc., Post Acute Recovery, Inc., Micro Interventional Devices, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.